Juan Vaz
Karolinska Institutet · 41 works · 500 citations · h-index 10
Top works
- SPARC
- Phosphatidylethanol levels distinguish steatotic liver disease subgroups and are associated with risk of major liver outcomes
- Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study
- Intervention on toll-like receptors in pancreatic cancer
- The People-First Liver Charter
- Controversial role of toll-like receptors in acute pancreatitis
- Metabolic dysfunction‐associated steatotic liver disease has become the most common cause of hepatocellular carcinoma in Sweden : A nationwide cohort study
- The MetALD-ALD Prediction Index: A Phosphatidylethanol-Driven Biomarker Panel for Identifying Individuals With Steatotic Liver Disease and Excessive Alcohol Use
- Socioeconomic and marital status among liver cirrhosis patients and associations with mortality: a population-based cohort study in Sweden
- Frequently Recurrent Takotsubo Syndrome in COPD
- Unrecognized liver cirrhosis is common and associated with worse survival in hepatocellular carcinoma: A nationwide cohort study of 3473 patients
- Targeting population groups with heavier burden of hepatocellular carcinoma incidence: A nationwide descriptive epidemiological study in Sweden
- Cirrhosis incidence across socioeconomic and demographic groups in Sweden: a register-based cohort study
- Editorial: MetALD ‐ ALD Prediction Index—A Scalable Biomarker for Alcohol Phenotyping Beyond PEth
- Socioeconomic inequalities in diagnostics, care and survival outcomes for hepatocellular carcinoma in Sweden: a nationwide cohort study
- Non-liver comorbidity in patients with hepatocellular carcinoma and curative treatments – a Swedish national registry study
- Socioeconomic disparities in incidence, treatment, and survival of intrahepatic cholangiocarcinoma: insights from a nationwide cohort study in Sweden
- Systemic treatment paradigms for unresectable and advanced hepatocellular carcinoma in Europe
- Risk of tumour recurrence following curative treatment of hepatocellular carcinoma
- Phosphatidylethanol for monitoring alcohol use after liver transplantation